drugset / Trial / NCT00850161

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

NCT00850161

Phase 2 Withdrawn CPEX Pharmaceuticals Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if glucose peaks higher and earlier after a meal when a patient is given intranasal insulin instead of conventional insulin treatment.

Timeline

Start
2009-07
Primary completion
2009-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 100 iu Intranasal
Comparator insulin aspart Protein / enzyme biologic Subcutaneous